VBI Vaccines appoints chief commercial officer

John Dillman joins the organization from Syneos Health.

Mackenzie Allen

July 18, 2022

1:15 pm

VBI Vaccines has tapped John Dillman as chief commercial officer. In that role, he has been charged with leading VBI’s commercial strategy, sales and sales operations, including the commercialization of VBI’s hepatitis vaccine PreHevbrio.

Prior to formally arriving at VBI, Dillman was the company’s commercial lead at Syneos Health. VBI has had a commercialization partnership with Syneos Health since 2019.

From Our Partners

HUB services, patient engagement, and specialty pharmacy: One patient support ecosystem with three core components

Partner Content

HUB services, patient engagement, and specialty pharmacy: One patient support ecosystem with three core components

The evolution of patient needs and rising consumer expectations are shaping a new era in healthcare — one that calls for a paradigm shift in the pharmaceutical industry's approach to patient support.

Omnichannel activation without omniburden

Partner Content

Omnichannel activation without omniburden

Explore solutions for practically implementing omnichannel approaches into your go-to-market activation.

Taking a patient-centric approach to privacy

Partner Content

Taking a patient-centric approach to privacy

This podcast will explore ways to deliver tailored content that activates, educates and empowers patients while prioritizing privacy and consent.

Living brands: How to build brands in the age of omnichannel

Partner Content

Living brands: How to build brands in the age of omnichannel

This podcast looks at how to leverage advancements in data, technology, AI and content development in order to become a Living Brand.